MeSH tree: N06.850.520.830
The cost-effectiveness of the immunotherapy drug pembrolizumab for patients with locally advanced head and neck squamous cell carcinoma may depend on biomarker results, according to a new study.
Aug 10, 2026
0
3
The way women are screened for breast cancer in Australia is changing. According to a newly released review, this means moving away from screening based largely on someone's age. Instead, screening would be tailored according ...
Aug 9, 2026
0
22
Community gathering places, where residents lead group activities, have been promoted across Japan as part of long-term care prevention efforts to extend healthy life expectancy. These often involve exercise and social interaction ...
Jul 31, 2026
0
6
Patients with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer experienced a 58% reduction in the risk of disease progression or death when treated with atezolizumab ...
Jul 30, 2026
0
7
An international team of researchers led by the Barcelona Institute for Global Health (ISGlobal) and the University of Bonn—with participation from the Barça Innovation Hub (BIHUB), FC Barcelona's medical department and the ...
Jul 28, 2026
0
7
Individuals with psoriasis have a higher burden of myocardial dysfunction, independent of cardiometabolic risk, according to a study published online July 17 in the Journal of the European Academy of Dermatology and Venereology.
Jul 23, 2026
0
5
Many people assume that some memory decline is an inevitable consequence of getting older. But a select group of older adults, known as "SuperAgers," reach their 80s and 90s while retaining memory performance as good as or ...
Jul 22, 2026
0
101
The prevalence of health care-associated infections was lower in 2023 than in 2015 in the United States, according to a study published in the New England Journal of Medicine.
Jul 20, 2026
0
5
For patients with newly diagnosed multiple myeloma not undergoing an autologous stem cell transplant, indefinite lenalidomide maintenance has long been standard care despite limited evidence to guide the optimal duration ...
Jul 16, 2026
0
7
Researchers have validated a genetic scoring tool that may help physicians diagnose idiopathic pulmonary fibrosis and identify which patients are at greatest risk for severe outcomes, including death or the need for a lung ...
Jul 7, 2026
0
7
